| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyCellularComponent | specific granule | 2.52e-03 | 160 | 10 | 2 | GO:0042581 | |
| GeneOntologyCellularComponent | synaptic vesicle membrane | 3.14e-03 | 179 | 10 | 2 | GO:0030672 | |
| GeneOntologyCellularComponent | exocytic vesicle membrane | 3.14e-03 | 179 | 10 | 2 | GO:0099501 | |
| GeneOntologyCellularComponent | transport vesicle membrane | 8.18e-03 | 293 | 10 | 2 | GO:0030658 | |
| GeneOntologyCellularComponent | synaptic vesicle | 8.56e-03 | 300 | 10 | 2 | GO:0008021 | |
| GeneOntologyCellularComponent | exocytic vesicle | 9.69e-03 | 320 | 10 | 2 | GO:0070382 | |
| MousePheno | abnormal sperm physiology | 6.52e-05 | 447 | 8 | 4 | MP:0004543 | |
| MousePheno | impaired acrosome reaction | 2.10e-04 | 39 | 8 | 2 | MP:0004542 | |
| MousePheno | abnormal acrosome reaction | 2.80e-04 | 45 | 8 | 2 | MP:0013287 | |
| MousePheno | decreased sperm progressive motility | 1.38e-03 | 100 | 8 | 2 | MP:0020451 | |
| MousePheno | abnormal sperm progressive motility | 1.41e-03 | 101 | 8 | 2 | MP:0020450 | |
| Domain | Cysteine_rich_secretory | 9.46e-07 | 3 | 11 | 2 | IPR013871 | |
| Domain | Crisp | 9.46e-07 | 3 | 11 | 2 | PF08562 | |
| Domain | ShKT_dom | 3.15e-06 | 5 | 11 | 2 | IPR003582 | |
| Domain | SHKT | 3.15e-06 | 5 | 11 | 2 | PS51670 | |
| Domain | Allrgn_V5/Tpx1_CS | 1.42e-05 | 10 | 11 | 2 | IPR018244 | |
| Domain | CRISP_1 | 1.73e-05 | 11 | 11 | 2 | PS01009 | |
| Domain | CRISP_2 | 1.73e-05 | 11 | 11 | 2 | PS01010 | |
| Domain | SCP | 3.30e-05 | 15 | 11 | 2 | SM00198 | |
| Domain | - | 3.30e-05 | 15 | 11 | 2 | 3.40.33.10 | |
| Domain | Allrgn_V5/Tpx1 | 3.30e-05 | 15 | 11 | 2 | IPR001283 | |
| Domain | CAP | 3.30e-05 | 15 | 11 | 2 | PF00188 | |
| Domain | CAP_domain | 3.30e-05 | 15 | 11 | 2 | IPR014044 | |
| Domain | zf-C2H2_6 | 1.40e-02 | 314 | 11 | 2 | PF13912 | |
| Pubmed | 9.09e-08 | 2 | 11 | 2 | 10048974 | ||
| Pubmed | 9.09e-08 | 2 | 11 | 2 | 10580147 | ||
| Pubmed | 9.09e-08 | 2 | 11 | 2 | 11562501 | ||
| Pubmed | Differential androgen regulation of the murine genes for cysteine-rich secretory proteins (CRISP). | 9.09e-08 | 2 | 11 | 2 | 9428696 | |
| Pubmed | 2.73e-07 | 3 | 11 | 2 | 34422816 | ||
| Pubmed | 2.73e-07 | 3 | 11 | 2 | 35063506 | ||
| Pubmed | 2.73e-07 | 3 | 11 | 2 | 33037689 | ||
| Pubmed | 2.73e-07 | 3 | 11 | 2 | 8665901 | ||
| Pubmed | 9.09e-07 | 5 | 11 | 2 | 20625511 | ||
| Pubmed | The complexity of antisense transcription revealed by the study of developing male germ cells. | 1.39e-05 | 18 | 11 | 2 | 16458478 | |
| Cytoband | 6p12.3 | 3.27e-05 | 36 | 11 | 2 | 6p12.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr6p12 | 5.13e-04 | 142 | 11 | 2 | chr6p12 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19p13 | 1.49e-02 | 797 | 11 | 2 | chr19p13 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 2.90e-02 | 718 | 7 | 2 | 28 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.37e-05 | 199 | 11 | 3 | 8587bd98de7767a575088afbea07a1feb4516b9b | |
| ToppCell | Parenchymal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.37e-05 | 199 | 11 | 3 | 5cea0d9e261903e0eaad60c28a07dff72ce65027 | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Syt6-Excitatory_Neuron.Slc17a7.Syt6-Slc24a2_(Cadm2+,_not_selective)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 4.88e-05 | 43 | 11 | 2 | 7027858b46c0aabec290ed3888201a1b39e10552 | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Syt6-Excitatory_Neuron.Slc17a7.Syt6-Slc24a2_(Cadm2+,_not_selective)-|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 4.88e-05 | 43 | 11 | 2 | 0282410243ba125ec13fd6af737ddf952e493280 | |
| ToppCell | TCGA-Endometrium-Solid_Tissue_Normal-Endometrium_normal_tissue-Endometrium-4|TCGA-Endometrium / Sample_Type by Project: Shred V9 | 3.27e-04 | 111 | 11 | 2 | 7822945c9fc0ac6d9bc4305a078e19758df0e4d6 | |
| ToppCell | tumor_Lung-Myeloid_cells-Pleural_Mac|Myeloid_cells / Location, Cell class and cell subclass | 5.64e-04 | 146 | 11 | 2 | 8b2d104fdb0fdb09410450c6c651e1edb00cae44 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.72e-04 | 147 | 11 | 2 | 9bc4185920b2b0f1fd5c6e2ec5583b9cd49c2efd | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.72e-04 | 147 | 11 | 2 | 9b0f87a6dd5224c2b06deafeae04a1b04e53eb75 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m-Endothelial-Endothelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.27e-04 | 154 | 11 | 2 | c6f1a0806d492b1f01cded2daffaf3f13422deb6 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m-Endothelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.27e-04 | 154 | 11 | 2 | 665885d8aca168513ab7a65f70d52181c821eb78 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m-Endothelial-endothelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.27e-04 | 154 | 11 | 2 | 3c64111e2ca1bb04ddd1ecb19938a307778ff7eb | |
| ToppCell | droplet-Liver-Hepatocytes-18m-Myeloid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.60e-04 | 158 | 11 | 2 | d3446fc98eff09c3626b47a2c90d07cd985378b5 | |
| ToppCell | droplet-Liver-Hepatocytes-18m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.60e-04 | 158 | 11 | 2 | df614450e10629dc9115d7365397663e82f9e48f | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-lymphatic_endothelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.85e-04 | 161 | 11 | 2 | fb59d96c2aa9e4654f02bf6ce36bf832776cb4dd | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.85e-04 | 161 | 11 | 2 | c53c461fc721a7960cef86662f49e2a495520701 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex-lymphatic_endothelial_cell_of_renal_cortex|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.94e-04 | 162 | 11 | 2 | 2ac02523348660e514d464f8f2434ee0c312d784 | |
| ToppCell | droplet-Marrow-BM-30m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.94e-04 | 162 | 11 | 2 | 75df7ff779a3b9159ba97d852da1f8df650b9ce5 | |
| ToppCell | TCGA-Head_and_Esophagus-Solid_Tissue_Normal-Head_and_Neck-Head_and_Neck_normal_tissue-2|TCGA-Head_and_Esophagus / Sample_Type by Project: Shred V9 | 7.02e-04 | 163 | 11 | 2 | 2dfd11f5803822ba01b92adf4395a3b3adda68f5 | |
| ToppCell | Ciliated_cells-A-Donor_01|World / lung cells shred on cell class, cell subclass, sample id | 7.02e-04 | 163 | 11 | 2 | 43194c6127df1ce3d29242f719645de3c11fd7c0 | |
| ToppCell | 367C-Lymphocytic-NK_cells-NK_cell_E|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 7.37e-04 | 167 | 11 | 2 | b5d15773be32cd277125fd3b4056a8fefaefa5ec | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L4-5_RORB_AIM2|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.37e-04 | 167 | 11 | 2 | 4c8bb68ee2bf7b794940b34df96f38f3f69507e9 | |
| ToppCell | Control-NK|Control / Disease group and Cell class | 7.46e-04 | 168 | 11 | 2 | 683d389c8a1e791bfc773e63148115a21a6566db | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Epithelial-Tuft-related-Microfold_cell|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.54e-04 | 169 | 11 | 2 | a54a8494c1feff29d77ab4737fcfabc84ace5c94 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.90e-04 | 173 | 11 | 2 | 0c74bdb40e635d906fd180412c23bf7fed61621e | |
| ToppCell | ILEUM-inflamed-(1)_T_cell-(1)_T_(gd)|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 7.90e-04 | 173 | 11 | 2 | 62f2f42f54c9c6941bf888956be40230f92c883e | |
| ToppCell | LPS-IL1RA+antiTNF|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.27e-04 | 177 | 11 | 2 | b7fee75de7e96924af488a5baa2334711889ae7c | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.27e-04 | 177 | 11 | 2 | c274fbdc141855ff4581d437d4997c64cc193278 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_medulla|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.27e-04 | 177 | 11 | 2 | c8a51e480b978dc0ded85583261f2c892e085be8 | |
| ToppCell | TCGA-Head_and_Esophagus-Solid_Tissue_Normal-Head_and_Neck-Head_and_Neck_normal_tissue|TCGA-Head_and_Esophagus / Sample_Type by Project: Shred V9 | 8.27e-04 | 177 | 11 | 2 | 675003fbecee1b86919d1a6eeb268e1ca298f714 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_medulla-lymphatic_endothelial_cell_of_renal_medulla|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.27e-04 | 177 | 11 | 2 | f5e6df5cafd003bbfbb3b634ee58d0b1e2be5cc7 | |
| ToppCell | TCGA-Head_and_Esophagus-Solid_Tissue_Normal-Head_and_Neck|TCGA-Head_and_Esophagus / Sample_Type by Project: Shred V9 | 8.27e-04 | 177 | 11 | 2 | 72d144289167f200ac9f006d130de31e45568484 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-B-B_cell-B_naive-B_naive-11|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.27e-04 | 177 | 11 | 2 | 3535575686c9700ab72700aae6f2070ebbb50044 | |
| ToppCell | COVID-19-Heart-Lymph_EC|Heart / Disease (COVID-19 only), tissue and cell type | 8.46e-04 | 179 | 11 | 2 | 411620201a860716a8773b92f50f7b94ef34a586 | |
| ToppCell | PND07-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.46e-04 | 179 | 11 | 2 | bf012825e88626e59cd1deebf67c2cd269ce4829 | |
| ToppCell | 3'-Broncho-tracheal_SMG-Epithelial-Epithelial_transtional-secretory-SMG_mucus_secreting_cell-SMG_mucous-SMG_mucous_L.0.6.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.55e-04 | 180 | 11 | 2 | 8af51245ac1269f318268f574cfaddb0b8c80a53 | |
| ToppCell | facs-Large_Intestine-Distal-24m-Epithelial-nan|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.64e-04 | 181 | 11 | 2 | 75340f0c06977c88f9d2e56265f4aa84d706d2c6 | |
| ToppCell | B_cell_maturation-immature_B_cell|World / Lineage and Cell class | 8.74e-04 | 182 | 11 | 2 | 2c7c51ebc4125d8a33454ffee0b143579ce5e451 | |
| ToppCell | 10x5'v1-week_12-13-Myeloid_neutrophil-granulo-neutrophil-myelocyte|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 8.74e-04 | 182 | 11 | 2 | 52eac2f892ea7f26731e0b21c578fd2665a1657a | |
| ToppCell | 390C-Lymphocytic-CD4_T-cell-Treg_cell_3|390C / Donor, Lineage, Cell class and subclass (all cells) | 8.83e-04 | 183 | 11 | 2 | 228092290dbb08785c4eda224e3ad03e99e10fab | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.83e-04 | 183 | 11 | 2 | 2f0ee40e69ad1259e56e8ee4b352736900eb8901 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.83e-04 | 183 | 11 | 2 | 7eae9b3b4d1c9b135fa7cff348393d4adec474b4 | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Neuronal-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.93e-04 | 184 | 11 | 2 | e33bb572af9dfd11127105f1ac99bc958a7cafbb | |
| ToppCell | cellseq-Epithelial-Epithelial_Glandular-Serous|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.93e-04 | 184 | 11 | 2 | f0cbb5b76e092be4188a9804ef5cf7a83cd7644f | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-NPC-like-NPC-like_neural-B|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.93e-04 | 184 | 11 | 2 | cd2919dc8e90d03f57eb43f59f7da9bcd676496e | |
| ToppCell | cellseq-Epithelial-Epithelial_Glandular-Serous-Serous|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.93e-04 | 184 | 11 | 2 | 5433ba7bbab553ff668619822d1a9208e15cd59f | |
| ToppCell | mild-Myeloid-Immature_Neutrophils_1|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 9.03e-04 | 185 | 11 | 2 | d747bc91fc276f12a5572ab0223fc71f829a5110 | |
| ToppCell | Mild-CD4+_T|Mild / Disease group and Cell class | 9.03e-04 | 185 | 11 | 2 | c28ecb63146de1b02418e5a4fad0ae7c2b66a41d | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c05-ZNF683|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.22e-04 | 187 | 11 | 2 | d17352f769c3c66601b65d060626eecff41b0482 | |
| ToppCell | SMG-Goblet|World / shred by cell class for bronchial biopsy | 9.22e-04 | 187 | 11 | 2 | 5178118bdec91495253c88f58fd908cf831de7ef | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-SMG_serous_secreting_cell-SMG_serous_(nasal)-SMG_serous_(nasal)_L.0.6.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.32e-04 | 188 | 11 | 2 | 02b3aae071ff1f469d52a4d513a4eb46ae70bba3 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-SMG_serous_secreting_cell-SMG_serous_(nasal)-SMG_serous_(nasal)_L.0.6.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.42e-04 | 189 | 11 | 2 | 29423dc66a8af71293b2e1670acc6c34dfe63608 | |
| ToppCell | mild-Myeloid-Immature_Neutrophils_1|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 9.42e-04 | 189 | 11 | 2 | 94dd5d4d815449feff7ce157fe7f8234f7c81422 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-SMG_serous_secreting_cell-SMG_serous_(nasal)-SMG_serous_(nasal)_L.0.6.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.52e-04 | 190 | 11 | 2 | 70b14b649ae893513e6d61b7288d6f6df97f09d9 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-SMG_serous_secreting_cell-SMG_serous_(nasal)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.52e-04 | 190 | 11 | 2 | e3a07dcffb75375693738bef1668353f4cdba5d7 | |
| ToppCell | 10x_3'_v3-spleen_(10x_3'_v3)-myeloid-myeloid_monocytic-intermediate_monocyte|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 9.52e-04 | 190 | 11 | 2 | 896b5825edb30fe62cbbed6078570c1f8057a99e | |
| ToppCell | control-Myeloid-Immature_Neutrophils_1|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 9.52e-04 | 190 | 11 | 2 | 38e83337c70c8734b63f8589ba59e0f98603f94c | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-SMG_serous_secreting_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.52e-04 | 190 | 11 | 2 | f6f8451eef5a387b0a1fd2e90ab965928ea2ea82 | |
| ToppCell | 3'-Broncho-tracheal_SMG-Epithelial-Epithelial_transtional-secretory-SMG_tracheobronchial_serous_cell-SMG_serous_(bronchial)-SMG_serous_(bronchial)_L.0.6.1.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.62e-04 | 191 | 11 | 2 | 13460059a0c1ed9f476cef28b8ad4c06349056c6 | |
| ToppCell | Ciliated-cil-3|World / Class top | 9.72e-04 | 192 | 11 | 2 | 4989ebb8812b8af1870599acd932849122c05a29 | |
| ToppCell | ILEUM-inflamed-(7)_Endothelial_cell-(7)_Lymphatics|(7)_Endothelial_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 9.72e-04 | 192 | 11 | 2 | d43caf42ec744e895137f31ef65a990e250669d2 | |
| ToppCell | 10x_3'_v3-bone_marrow_(10x_3'_v3)|10x_3'_v3 / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 9.72e-04 | 192 | 11 | 2 | 072281344d58e85c9a290750b488d0c101f75d54 | |
| ToppCell | control-Myeloid-Immature_Neutrophils_1|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 9.72e-04 | 192 | 11 | 2 | 9f12b79d661ef0f57c2c924e8ecc24a46ea996d2 | |
| ToppCell | 3'-Broncho-tracheal_SMG-Epithelial-Epithelial_transtional-secretory-SMG_tracheobronchial_serous_cell-SMG_serous_(bronchial)-SMG_serous_(bronchial)_L.0.6.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.72e-04 | 192 | 11 | 2 | 48b69d6f46e583378186d2993a202f9584688bfa | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-Z|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.72e-04 | 192 | 11 | 2 | 8dc3016601148243196e925641c9507e9d58c9e0 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c04-COTL1|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.82e-04 | 193 | 11 | 2 | 778fcf8448e81fe18972d97ea8a30ab036d16fe5 | |
| ToppCell | 3'-Broncho-tracheal_SMG-Epithelial-Epithelial_transtional-secretory-SMG_tracheobronchial_serous_cell-SMG_serous_(bronchial)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.82e-04 | 193 | 11 | 2 | 56145861ef5e7655db9ad0d11b82f72dcadf285d | |
| ToppCell | 3'-Broncho-tracheal_SMG-Epithelial-Epithelial_transtional-secretory-SMG_tracheobronchial_serous_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.82e-04 | 193 | 11 | 2 | 3d1710a6060d3a70994a206334ccb16cd63e5f20 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.92e-04 | 194 | 11 | 2 | cb0422e7607dbd77204428b7e2c70dfe14a6ca11 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.92e-04 | 194 | 11 | 2 | 64535db0420e53e4d777d2333b5051e63e8a3373 | |
| ToppCell | 3'-Broncho-tracheal_SMG-Epithelial|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.92e-04 | 194 | 11 | 2 | f1d057c4bf57e75ad5a821e5f3de335dbff69062 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c03-GZMK|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.92e-04 | 194 | 11 | 2 | b0a7f5ca0c6f4f5764a8b35b5de80d82b828c66c | |
| ToppCell | 3'-Broncho-tracheal_SMG|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.92e-04 | 194 | 11 | 2 | 42558822d7e260e7d8cf2539f1f7426e5774edfb | |
| ToppCell | 3'-Broncho-tracheal_SMG-Epithelial-Epithelial_transtional-secretory|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.92e-04 | 194 | 11 | 2 | 0d97dee07846416c77a861994912a9207f29ceb3 | |
| ToppCell | severe-Myeloid-Immature_Neutrophils_1|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.00e-03 | 195 | 11 | 2 | becad890a420267ca41e98e61a8da343b51e1945 | |
| ToppCell | IPF-Endothelial-Lymphatic|Endothelial / Disease state, Lineage and Cell class | 1.00e-03 | 195 | 11 | 2 | de88e9d22044b4b3e29676ad02b3e9299cc920ad | |
| ToppCell | Endothelial_cells-Endothelial-B|Endothelial_cells / lung cells shred on cell class, cell subclass, sample id | 1.01e-03 | 196 | 11 | 2 | 36f95f9ef74eb951e41ef46fd136ceaef45208fc | |
| ToppCell | Tracheal-10x3prime_v2-Epithelial-Epi_airway_secretory-Secretory_Club|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.01e-03 | 196 | 11 | 2 | d5f9168001e60bafec17fe6c702e68f5528edc20 | |
| ToppCell | severe-Myeloid-Immature_Neutrophils_1|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.02e-03 | 197 | 11 | 2 | 9599319dd1f80c81356a8624131566cc76d77d7e | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.02e-03 | 197 | 11 | 2 | 82b8e22317cad6d3786bd70d91107007c0ccd7cd | |
| ToppCell | tumor_Lung-Endothelial_cells-Lymphatic_ECs|Endothelial_cells / Location, Cell class and cell subclass | 1.02e-03 | 197 | 11 | 2 | a05237ee6d31d9eab491dd7007859d6285cf1424 | |
| ToppCell | Sepsis-URO-Others|URO / Disease, condition lineage and cell class | 1.03e-03 | 198 | 11 | 2 | 6caab5266da666cfbe92ac1ace26ad2004e5aa09 | |
| ToppCell | Sepsis-URO-Others-RBC|URO / Disease, condition lineage and cell class | 1.03e-03 | 198 | 11 | 2 | d35e9d0952b3f7cd5d0d1a69bad2ae81af8eed50 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.03e-03 | 198 | 11 | 2 | bdabdb11217ea16e5863aa6bfb0f04d48b17f81e | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.04e-03 | 199 | 11 | 2 | 214a6a267e77e5508867b9eb48c4fbc7855ed0a0 | |
| ToppCell | COVID-19_Severe-immature_Neutrophil-|COVID-19_Severe / Disease condition and Cell class | 1.04e-03 | 199 | 11 | 2 | 42ea0c19c455bdb0ae89b428d09c333104c670dc | |
| ToppCell | Bronchial-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.04e-03 | 199 | 11 | 2 | 5f7da3eab58ace6cddb3179a415cd839d5767958 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.04e-03 | 199 | 11 | 2 | 725610310e5c5fd7120c0be9acb55bf152026ddd | |
| ToppCell | COVID-19_Severe-immature_Neutrophil|COVID-19_Severe / Disease condition and Cell class | 1.04e-03 | 199 | 11 | 2 | f82fa9d651e78f9ebbe6264e00a48c54b1786a69 | |
| ToppCell | Macroglial-Oligodendrocytes|Macroglial / cells hierarchy compared to all cells using T-Statistic | 1.05e-03 | 200 | 11 | 2 | 4dbac2f2587e87ca5a0622f50439bb5447e93c7f | |
| ToppCell | Caecum-T_cell-gd_T|T_cell / Region, Cell class and subclass | 1.05e-03 | 200 | 11 | 2 | 564117144a3059017a07d66f718b9b5a1f18265b | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_submucosal-gland|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.05e-03 | 200 | 11 | 2 | a3e044468de437948b63c517e0a4773cc247c906 | |
| ToppCell | Parenchyma_Control_(B.)-Epithelial-TX-Ciliated|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 1.05e-03 | 200 | 11 | 2 | a521cf837cadf280505ff9d7e641a205af7d6513 | |
| ToppCell | Macroglial-Oligodendrocytes-OPALIN----L1-6|Macroglial / cells hierarchy compared to all cells using T-Statistic | 1.05e-03 | 200 | 11 | 2 | 272909f4354f3ae22e2b2f8f35970e6b0e92cfe2 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.05e-03 | 200 | 11 | 2 | 3ce8a2db8c25e1169a0a544f644a63104749c5ee | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|Control_saline / Treatment groups by lineage, cell group, cell type | 1.05e-03 | 200 | 11 | 2 | a799fc7bb83ad0524362cb5010df949741fb7bf3 | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-Ciliated-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.05e-03 | 200 | 11 | 2 | 918b576fd9491d23c2bb9d663fa5fb3505cb1c7e | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.05e-03 | 200 | 11 | 2 | 091a18d6efed81cab99955c3047f172170f70476 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.05e-03 | 200 | 11 | 2 | 0bfd41c12887479ceb62c3db0a3c3ba5007eb62b | |
| ToppCell | Macroglial-Oligodendrocytes-OPALIN--|Macroglial / cells hierarchy compared to all cells using T-Statistic | 1.05e-03 | 200 | 11 | 2 | 26b989e30bbbaf30904ced03f6aae3dea25c732c | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.05e-03 | 200 | 11 | 2 | 159377d904394d91e09913131e9a93e08189955a | |
| Disease | level of cysteine-rich secretory protein 2 in blood serum | 1.03e-07 | 2 | 10 | 2 | OBA_2041144 | |
| Disease | cysteine-rich secretory protein 2 measurement | 2.89e-06 | 8 | 10 | 2 | EFO_0801511 | |
| Disease | calcium measurement | 1.82e-02 | 628 | 10 | 2 | EFO_0004838 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PNQDSLKYYYVCQYC | 156 | P16562 | |
| LKYYYVCQYCPAGNN | 161 | P16562 | |
| NYNRVSKCILYCFYK | 851 | Q9Y2Q0 | |
| LNFLKLCKIKYYNYC | 26 | Q8WUA2 | |
| QYYCVDCYKNFVAKK | 206 | Q13642 | |
| YKSVVYYQVKQPCWY | 496 | Q9H7D0 | |
| YCPNQKVLKYYYVCQ | 156 | P54108 | |
| KVLKYYYVCQYCPAG | 161 | P54108 | |
| NKPHYYQLFCYIYQA | 1071 | A0AVI2 | |
| RCVQYNKSCYKAYEY | 1226 | Q8NDW8 | |
| YQEYGQKPYKCTYCK | 61 | Q96I27 | |
| PYECKQCGKTFIYYQ | 196 | P17017 | |
| KQCPYCLLYKYMYIH | 626 | Q8N8K9 |